ClariVest Asset Management’s Fulcrum Therapeutics FULC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-106,977	Closed	-$722K	–	879
2023 Q4	$722K	Buy	106,977 +2,577	+2%	+$17.4K	0.04%	318
2023 Q3	$464K	Buy	+104,400	New	+$464K	0.03%	351
2021 Q4	–	Sell	-19,700	Closed	-$556K	–	771
2021 Q3	$556K	Buy	+19,700	New	+$556K	0.02%	427